Cyclopentenone prostaglandins (CyPGs), such as 15-deoxy-Δ 12,14 -prostaglandin J 2 (15d-PGJ 2 ), are active prostaglandin metabolites exerting a variety of biological effects that may be important in the pathogenesis of neurological diseases. Ubiquitin-C-terminal hydrolase L1 (UCH-L1) is a brain specific deubiquitinating enzyme whose aberrant function has been linked to neurodegenerative disorders. We report that [15d-PGJ 2 ] detected by quadrapole mass spectrometry (MS) increases in rat brain after temporary focal ischemia, and that treatment with 15d-PGJ 2 induces accumulation of ubiquitinated proteins and exacerbates cell death in normoxic and hypoxic primary neurons. 15d-PGJ 2 covalently modifies UCH-L1 and inhibits its hydrolase activity. Pharmacologic inhibition of UCH-L1 exacerbates hypoxic neuronal death while transduction with a TAT-UCH-L1 fusion protein protects neurons from hypoxia. These studies indicate that UCH-L1 function is important in hypoxic neuronal death and that excessive production of CyPGs after stroke may exacerbate ischemic injury by modification and inhibition of UCH-L1. Published by Elsevier Inc.
Introduction
Expression of cyclooxygenase-2 (COX-2) is induced after cerebral ischemia and exacerbates ischemic neuronal injury through a variety of mechanisms (Nakayama et al., 1998) . PGD 2 , the major COX-2 product synthesized in the central nervous system, is dehydrated to generate biologically active cyclopentenone prostaglandins (CyPGs) of the J 2 series, including PGJ 2 , Δ
12
-PGJ 2 and 15-deoxy-Δ 12,14 -PGJ 2 (15d-PGJ 2 ) (Uchida and Shibata, 2008) . These CyPGs are characterized by the presence of a cyclopentenone ring which can directly modify nucleophiles such as free sulfhydryls in cysteine residues of cellular proteins. While CyPGs can covalently modify cysteines in a large number of proteins, CyPGs are thought to play specific signal transduction roles by high-affinity interactions with specific proteins such as PPARγ, and regulate cell proliferation and lipid metabolism (Kliewer et al., 1995; Shiraki et al., 2005) . However, 15d-PGJ 2 can also modify many other cellular proteins and therefore has many PPARγ-independent effects including protein turnover inhibition, inducing cytoskeletal dysfunction and apoptosis (Ogburn and Figueiredo-Pereira, 2006; Shibata et al., 2003b; Stamatakis et al., 2006) . These PPARγ-independent effects of CyPGs may include disruption of the ubiquitin-proteasome pathway (UPP) (Li et al., 2004b) .
The UPP is responsible for the degradation of mutant or misfolded proteins in cells and plays a critical role in maintaining cell homeostasis (Vernace et al., 2007) . Interruption of UPP function results in the accumulation and aggregation of ubiquitinated proteins (Ub-proteins) in cells, which are the pathological hallmark of some neurodegenerative diseases including Parkinson's disease (PD) and Alzheimer's disease (AD) (Giasson and Lee, 2003; Oddo, 2008) . Ub-proteins also accumulate in neurons after global and focal cerebral ischemia (Ge et al., 2007; Liu et al., 2005) , and the aggregation of Ub-proteins may contribute to cell stress following ischemia, thereby amplifying neuronal damage (Meller, 2009 ). Ubiquitin C-terminal hydrolase L1 (UCH-L1), an important component of the neuronal UPP, is selectively expressed in brain (Setsuie and Wada, 2007) . Inhibition of UCH-L1 activity induces the aggregation of Ub-proteins and enhances cell death in primary neurons (Li et al., 2004b) . UCH-L1 is a major oxidative damage target in brain and that it can be modified by a variety of reagents under different pathological conditions (Choi et al., 2004) . These post-translational modifications to UCH-L1 may substantially change its structure and function, thereby disrupting the UPP function and cell survival (Choi et al., 2004; Kabuta et al., 2008; Liu et al., 2009; Meray and Lansbury, 2007) . 
